Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
8.62
-0.37 (-4.12%)
At close: Aug 10, 2026, 4:00 PM EDT
8.31
-0.31 (-3.60%)
After-hours: Aug 10, 2026, 7:49 PM EDT
Niki BioSolutions Employees
Niki BioSolutions had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,363,270
Market Cap
7.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Bolt Biotherapeutics | 23 |
| BioVie | 13 |
| Processa Pharmaceuticals | 12 |
| Ensysce Biosciences | 10 |
| AEON Biopharma | 8 |
| MetaVia | 8 |
| Immuron | 7 |
NIKI News
- 25 days ago - Aptorum Group Provides Update on DiamiR Biosciences Merger - GlobeNewsWire
- 4 weeks ago - Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference - GlobeNewsWire
- 7 weeks ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 7 weeks ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp
- 2 months ago - Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - GlobeNewsWire
- 5 months ago - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - GlobeNewsWire
- 6 months ago - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease - GlobeNewsWire
- 9 months ago - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference - GlobeNewsWire